There are 9 resources available
Welcome and Introduction
Presenter: C. Marchiò, IT E. Garralda, ES
Session: Welcome and Introduction
Resources:
Slides
Webcast
Mechanisms of gene fusion, fusion partners and consequences in oncogenesis Description, structure and function of TRK and NTRK in ontogenesis
Presenter: A. Vivancos, ES
Session: SESSION 1 Keynote lecture - Gene fusion in human cancer
Resources:
Slides
Webcast
Epidemiology and distribution of NTRK gene fusion in human tumours
Presenter: S. Ramon y Cajal, ES
Session: SESSION 2 Epidemiology and distribution of NTRK gene fusion in human tumours
Resources:
Slides
Webcast
Identification/testing methodologies and challenges
Presenter: C. Marchiò, IT
Session: SESSION 3 Identification/testing methodologies and challenges
Resources:
Slides
Webcast
Detection of gene fusion within the ESMO scale of Molecular Target (ESCAT)
Presenter: J. Mateo, ES
Session: SESSION 4 Detection of gene fusion within the ESMO scale of Molecular Target (ESCAT)
Resources:
Slides
Webcast
Present results with Larotectinib
Presenter: U. N. Lassen, DK
Session: SESSION 5 Clinical development of NTRK inhibitors
Resources:
Slides
Webcast
Tolerance profile and recommendation for use
Presenter: D. Planchard, FR
Session: SESSION 5 Clinical development of NTRK inhibitors
Resources:
Slides
Webcast
Multi-Kinases inhibitors with NTRK as a possible target
Presenter: D. Planchard, FR
Session: SESSION 5 Clinical development of NTRK inhibitors
Resources:
Slides
Webcast
Acquired resistance to NTRK Inhibitors and development of inhibitors targeting resistance mutations
Presenter: U. N. Lassen, DK
Session: SESSION 5 Clinical development of NTRK inhibitors
Resources:
Slides